Ajanta Pharma Limited (AJANTPHARM) — Announcement | 19 May 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Ajanta Pharma corrected the schedule for its analyst and institutional investor meetings, clarifying that the May 29 conference with 360 One Capital will be held at Grand Hyatt, Santacruz, and the June 8 meeting with ICICI Securities will take place at the company's headquarters. The revision fixes an earlier error in conference dates and confirms discussions will rely solely on previously published information, ensuring transparency for investors ahead of upcoming capital market engagements.

📄 View Original Announcement (PDF)

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AJANTPHARM — Free

Free account · 2 AI queries/day